Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Screening method and application of virus protein escape neutralizing antibody

A screening method and virus technology, applied in the fields of botanical equipment and methods, biochemical equipment and methods, applications, etc., can solve the problem of unable to suppress the rapid production of virus escape mutants

Pending Publication Date: 2022-07-12
NANJING MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although many antibodies against the S protein RBD are currently approved for use, potential escape mutations in RBD have an uncertain impact on vaccine development and antibody therapy at this stage
Immune evasion studies of mAbs show that even highly efficient neutralization does not prevent the rapid generation of virus escape mutants

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Screening method and application of virus protein escape neutralizing antibody
  • Screening method and application of virus protein escape neutralizing antibody
  • Screening method and application of virus protein escape neutralizing antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1 Construction of S protein expression vector with deletion of RBD fragment

[0043] Here, we used the existing SARS-CoV-2 S protein plasmid in the laboratory as a template (see the appendix for the S protein sequence and https: / / doi.org / 10.1038 / s41467-020-15562-9 for details of this plasmid). The transformation is accomplished by designing two pairs of different PCR upstream and downstream primers SNheIF and S929ecorvR, S1729ecorF and SBamHR (see the appendix for primer sequences), first using PCR technology (the product used in this laboratory is Novozan Phanta Max Super-Fidelity DNA Polymerase, the product used in the PCR technology in this example is this product, the specific reaction conditions and operation refer to the product manual) to respectively amplify the S protein parts at both ends of the RBD fragment. The primers used are SNheIF and S929ecorvR, and the primers used for the amplification of the right region of the RBD are S1729ecorF and SBamHR. ...

Embodiment 2

[0045] Example 2 Introduction of RBD fragment into S protein vector without RBD fragment

[0046] Using Error-PCR technology, using Quick-Mutation gene random mutation kit (Biyuntian D0219S), a set of primers S966ecorvF and S1713ecorR (see the appendix for primer sequences) were randomly mutated in the RBD region using RCR technology (for details, please refer to the above gene randomization Mutation reagent product instructions), and then the randomly mutated RBD fragment was digested by EcoRV and EcoRI restriction enzymes, and EcoRV and EcoRI were also used for the lenticmv-S(△RBD)-EGFP vector plasmid in Example 1. The RBD fragment was ligated with the lenticmv-S(△RBD)-EGFP plasmid using DNA ligase after restriction endonuclease digestion, and the ligated product was transformed and plated on an LB plate containing ampicillin resistance overnight. Growth, the next day colony PCR (Novizan 2×Taq Master Mix (Dye Plus), refer to the instruction manual for specific operations, se...

Embodiment 3

[0047] Example 3 Construction of S protein lentiviral plasmid library containing RBD mutation region

[0048] In order to expand the capacity of our S protein lentiviral plasmid library, we amplified the RBD fragment according to the operation in Example 2, and then compared the amplified RBD fragment and the lenticmv-S(ΔRBD)- The EGFP vector plasmid was digested with EcoRV and EcoRI restriction enzymes, respectively, and then the RBD fragment was ligated with the constructed lenticmv-S(ΔRBD)-EGFP vector (constructed in Example 1) with DNA ligase, and then the The enzyme-linked product was added to DH5α competent cells, placed on ice for 30 minutes, and then heat-shocked at 42°C for 30s. After heat shock, the competent cells were placed on ice to cool for 1-2 minutes, then 500ul LB medium was added, and the cells were incubated at 37°C on a shaker for 1-2 minutes. Shake at 200r for 30 minutes, and spread the competent enzyme-linked products on LB plates containing ampicillin. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a screening method and application of a virus protein escape neutralizing antibody, and the screening method comprises the following steps: constructing a random mutation library of virus protein, and introducing the random mutation library into a lentivirus plasmid vector to obtain a lentivirus plasmid library; the lentivirus plasmid library is used for packaging a pseudovirus, the pseudovirus is neutralized with a neutralizing antibody, cells expressing angiotensin converting enzyme 2 and cell serine protease are infected, cells expressing green fluorescence are screened out, DNA is extracted for sequence analysis, and a virus sequence capable of escaping the neutralizing antibody can be screened out. The screening system can be used for predicting the virus sequence of the escape neutralizing antibody, is simple, convenient and efficient, and provides a new platform for research of virus protein and hosts.

Description

technical field [0001] The invention belongs to the technical field of molecular biology, and in particular relates to a screening method and application of virus protein escape neutralizing antibodies. Background technique [0002] The 2019 novel coronavirus (SARS-CoV-2) is the third outbreak after the severe acute respiratory syndrome coronavirus (SARS-CoV) outbreak in 2002 and the Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in 2012. A highly pathogenic coronavirus. So far, the cumulative number of confirmed cases of new coronary pneumonia in the world has exceeded 100 million, and the cumulative number of deaths has exceeded 2.5 million, bringing unprecedented disaster to human society. [0003] With the large-scale spread of SARS-CoV-2 around the world, the traditionally long vaccine development process has been accelerated unprecedentedly, and at the same time, SARS-CoV-2 is also in the process of mutation. Recent studies have found that in the pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/867C12N15/65C12N15/50
CPCC12N15/86C12N15/65C07K14/005C12N2740/15043C12N2800/107C12N2770/20022Y02A50/30
Inventor 汤华民贾俊丽王宇航
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com